Nidec to Dissolve EAxle Joint Ventures in China and Europe Report Indicates Universal UHT Q1 2026 Results Meet Expectations Revenue NA Oportun OPRT Q1 2026 Earnings 021 EPS Surges Past 017 Estimates Veracyte VCYT Stock Up 785 Key Resistance at 4358 20260518 Strategy STRF Stock Steady at 10041 Support at 9539 20260520 Mango Billionaires Son Had Obsession With Money Judge Says NTRS Q1 2026 Earnings EPS Surges Past Estimates with 143 Surprise Elastic NV ESTC Q1 2026 Earnings Surprise EPS 073 Up Significant Spotify Surges After Unveiling AI Deal With Universal Music and LongTerm Guidance Yardeni Warns Fed May Need July Rate Hike to Appease Bond Vigilantes as Kevin Warsh Faces Pressure Nike Stock Rebound Prospects Remain Uncertain Amid Ongoing Challenges Bond Markets Signal Inflation Concerns as New Fed Leadership Emerges President Trump Delays AI Executive Order Citing Concerns Over Potential Obstacles to Innovation LIC Shares Extend Gains Ahead of Bonus Record Date Stock Up 7 in Three Sessions BTSGU Q1 2026 Earnings Strong EPS Beat of 2334 Surprise Amid Modest Stock Decline IOBT Q3 2025 Earnings Narrower Loss Exceeds Expectations as Pipeline Execution Continues CVNA Q1 2026 Earnings EPS Beats Estimates by Over 12 Stock Surges 6 Airship AI Holdings Q3 2025 Earnings EPS Falls Sharply Short of Estimates as Stock Rallies UAL Q1 2026 Earnings Strong EPS Beat Amid Improving Operational Efficiency Iran Standoff Intensifies Trump Rejects Counteroffer Threatening Energy Markets CMI Q1 2026 Earnings EPS Beat by 897 on Strong Operational Performance Allstate Q1 2026 Earnings EPS Beat by 4469 on Strong Underwriting Performance CONMED Corporation CNMD Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Higher Gloo Holdings Inc GLOO Q4 2025 Earnings Net Loss of 078 per Share Stock Declines 26 US Gold Corp Q1 2026 Earnings Significant Earnings Miss Amid No Revenue Generation Omada Health Q1 2026 Earnings Narrower Loss Beats Street Expectations MMSI Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response ANNX Q1 2026 Earnings Clinical Pipeline Progress Drives EPS Beat as Stock Dips on Broader Biotech Headwinds